Market authorization scenario for synthetic and semisynthetic drug products in Brazil
DOI:
https://doi.org/10.22239/2317-269X.01718Keywords:
Market Authorization; Generic Drug Products; Similar Drug Products; New Drug Application; National Police for Generic Drugs; AnvisaAbstract
Introduction:Market authorization is the government approval needed for drug product commercialization in Brazil. The requirements for market authorization were reorganized in 1999, when the Brazilian Health Regulatory Agency (Anvisa) was created and, also, when the National Police for Generic Drugs was implemented. Objective:About 20 year
after the implementation of the Police and the creation of Anvisa, this work aimed to describe the current scenario of market authorization for synthetic and semisynthetic drug products. This scenario aims to aid the decision-making process of regulators and regulated. Method:We used the System of Product and Services under Health Surveilance (Datavisa) to perform the data survey regarding valid market authorizations. Access to
this database is exclusive to Anvisa’s employees. Results:We found 6,454 valid market authorizations, accounting for 7,721 different drug products. More than 80,0% of the market authorizations are for generic and similar drug products. The national companies play an important role in the Brazilian pharmaceutical market, but we still identified some difficulty related to innovation. Among the main approved categories, we could find several over-the-counter drug products and, also, antibacterials for systemic use, drug products with action in the central nervous system, antineoplasic agents, and drug product for management of metabolic syndrome. The diseases treated by these drugs are highly prevalent in Brazil. Conclusions:The data showed the effectiveness of the adopted policies and can be used in the formulation of new policies related to the regularization of drug product in Brazil.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Health Surveillance under Debate: Society, Science & Technology (Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnología) – “Visa em Debate”
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT ALLOWANCE The author (s) hereinafter designated as the ASSIGNOR hereby assign and transfer, free of charge, the ownership of the copyrights related to this ARTICLE to the Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debate, represented by FUNDAÇÃO OSWALDO CRUZ, established at Av. Brasil, nº 4365, Manguinhos, Rio de Janeiro, RJ, Brazil, CEP 21045-900, under the conditions set out below: (a) The terms and conditions set forth in this Agreement shall apply to the following: 1. The ASSIGNOR declares that they s(he) is (are) the author (s) and owner (s) of the copyrighted property of the ARTICLE submitted. 2. The ASSIGNOR declares that the ARTICLE does not infringe the copyrights and / or other property rights of third parties, that the disclosure of images (if any) has been authorized and that they s(he) assume(s) full moral and / or property liability for its content, before third parties. 3. THE ASSIGNOR assigns and transfers all copyrights relating to the ARTICLE to the ASSIGNEE, especially the rights of editing, publication, translation into another language and reproduction by any process or technique. The ASSIGNEE becomes the exclusive owner of the rights related to the ARTICLE, and any reproduction, totally or partially, is prohibited in any other means of publicity, printed or electronic, without prior written authorization from the ASSIGNEE. 4. The assignment is free and, therefore, there will be no remuneration for the use of the ARTICLE by the ASSIGNEE.
